Please assess the completion status of the following clinical trial:

Trial Title: Prospective and Monocentric Study of the Incidence of Venous Thromboembolic Disease (VTE) in Spinal Cord Injury (SCI) Patient Between 3 and 12 Months After SCI

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age greater than 18 years.~* Patients having paraplegia or tetraplegia from C2 levels and above S1~* Paraplegia and tetraplegia of traumatic or non progressive SCI from traumatic or medical origin (ischemic, post-surgical, myelitis, benign tumor)~* Informed consent signed.~* stabilized respiratory situation with absence of chronic hypoxemia (hypoxemia being characterized by PaO2 steady state \<7.33 kPa)~* Patient not amputated.~* Absence of heart failure with ejection fraction below 30%~* Lack of solid neoplasia or progressive lymphoid haemopathy for 5 years, or myeloproliferative disorders (including polycythemia and thrombocythemia).~* No personal history of VTE and / or thrombophilia before the injury.~Exclusion Criteria:~* Unstabilized respiratory situation with presence of chronic hypoxemia (hypoxemia being characterized by PaO2 steady state \<7.33 kPa)~* Amputated Patient.~* Patients with heart failure with ejection fraction below 30%~* Solid neoplasia or progressive lymphoid haemopathy for 5 years, or myeloproliferative disorders (including polycythemia and thrombocythemia).~* Personal history of VTE and / or thrombophilia before the injury.~* Can not to follow during the study period~* Pregnant women~* Patient Refusal

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Spinal cord injury (SCI) patient (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).